Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Subscribe To Our Newsletter & Stay Updated
